An interventional study of Diet in Acromegaly, sponsored by Cedars-Sinai Medical Center. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-04-19.
Sponsored by Cedars-Sinai Medical Center · Not applicable, Interventional, and Treatment
Impact of low carbohydrate and low gluten diet on acromegaly progression, symptoms, complications, and treatment outcomes.
202 studies on the registry are indexed under Acromegaly; 19 are open to participants now.
This study's planned enrollment of 9 is below the median of 43 across 115 interventional studies indexed under Acromegaly.
Browse Acromegaly studies →Cedars-Sinai Medical Center is the lead sponsor of 456 studies on the registry; 107 are open to participants now.
Of its 65 completed or terminated interventional studies of FDA-regulated products, 49 (75%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Counseling, education, and implementation of low carbohydrate diet.
Other: Diet
Counseling, education, and implementation of low gluten diet.
Other: Diet
No change/intervention in diet. Continuation of standard diet.
Macronutrient diet changes.
Change in insulin-like growth factor 1 (IGF-1).
Change in IGF-1 will be assessed from baseline (pre-intervention) to end of follow up.
Time frame: 8 weeks
Change in growth hormone level (GH).
Change in GH level will be assessed from baseline (pre-intervention) to end of follow up.
Time frame: 8 weeks
Change in acromegaly related symptoms.
Change in acromegaly related symptoms will be assessed from baseline (pre-intervention) to end of follow up using Acromegaly Quality of Life Questionnaire (AcroQoL).
Time frame: 8 weeks
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Sep 2024; primary completion for Mar 2025, 5 months later.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.